Cargando…

Time to antibiotics is unrelated to outcome in pediatric patients with fever in neutropenia presenting without severe disease during chemotherapy for cancer

Fever in neutropenia (FN) remains an unavoidable, potentially lethal complication of chemotherapy. Timely administration of empirical broad-spectrum intravenous antibiotics has become standard of care. But the impact of time to antibiotics (TTA), the lag period between recognition of fever or arriva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koenig, Christa, Kuehni, Claudia E., Bodmer, Nicole, Agyeman, Philipp K. A., Ansari, Marc, Roessler, Jochen, von der Weid, Nicolas X., Ammann, Roland A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388602/ https://www.ncbi.nlm.nih.gov/pubmed/35982121 http://dx.doi.org/10.1038/s41598-022-18168-x

Ejemplares similares

Episodes of fever in neutropenia in pediatric patients with cancer in Bern, Switzerland, 1993–2012
por: Zermatten, Maxime G., et al.
Publicado: (2019)

Outcome prediction in pediatric fever in neutropenia: Development of clinical decision rules and external validation of published rules based on data from the prospective multicenter SPOG 2015 FN definition study
por: Santschi, Marina, et al.
Publicado: (2023)

Pediatric fever in neutropenia with bacteremia—Pathogen distribution and in vitro antibiotic susceptibility patterns over time in a retrospective single-center cohort study
por: Stergiotis, Melina, et al.
Publicado: (2021)

Pediatric patients at risk for fever in chemotherapy-induced neutropenia in Bern, Switzerland, 1993-2012
por: von Allmen, Annina N., et al.
Publicado: (2018)

Continuous recording of vital signs with a wearable device in pediatric patients undergoing chemotherapy for cancer—an operational feasibility study
por: Koenig, Christa, et al.
Publicado: (2021)

Protocol for a systematic review of time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN) and interventions aiming to reduce TTA
por: Koenig, Christa, et al.
Publicado: (2019)

Interventions aiming to reduce time to antibiotics (TTA) in patients with fever and neutropenia during chemotherapy for cancer (FN), a systematic review
por: Koenig, Christa, et al.
Publicado: (2019)

The Influence of Different Fever Definitions on the Rate of Fever in Neutropenia Diagnosed in Children with Cancer
por: Ammann, Roland A., et al.
Publicado: (2015)

The influence of different fever definitions on diagnostics and treatment after diagnosis of fever in chemotherapy-induced neutropenia in children with cancer
por: Wagner, Stéphanie, et al.
Publicado: (2018)

A Prospective Multicenter Study of Microbiologically Defined Infections in Pediatric Cancer Patients With Fever and Neutropenia: Swiss Pediatric Oncology Group 2003 Fever and Neutropenia Study
por: Agyeman, Philipp, et al.
Publicado: (2014)

Temperatures, diagnostics and treatment in pediatric cancer patients with fever in neutropenia, NCT01683370
por: Brack, Eva, et al.
Publicado: (2020)

Temperatures and blood counts in pediatric patients treated with chemotherapy for cancer, NCT01683370
por: Lavieri, Luana, et al.
Publicado: (2019)

Exploring the Association of Hemoglobin Level and Adverse Events in Children with Cancer Presenting with Fever in Neutropenia
por: Ammann, Roland A., et al.
Publicado: (2014)

Management of children with fever and neutropenia: results of a survey in 51 pediatric cancer centers in Germany, Austria, and Switzerland
por: Scheler, Max, et al.
Publicado: (2020)

Vital signs in pediatric oncology patients assessed by continuous recording with a wearable device, NCT04134429
por: Haemmerli, Marion, et al.
Publicado: (2022)

Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update
por: Lehrnbecher, Thomas, et al.
Publicado: (2023)

Clustering of health behaviours in adult survivors of childhood cancer and the general population
por: Rebholz, C E, et al.
Publicado: (2012)

Improving Time to Antibiotic Administration in Pediatric Patients with Fever and Suspected Neutropenia
por: Balsley, Kate, et al.
Publicado: (2021)

Diagnosing Preclinical Cardiac Dysfunction in Swiss Childhood Cancer Survivors: Protocol for a Single-Center Cohort Study
por: Schindera, Christina, et al.
Publicado: (2020)

Follow-Up Programs for Childhood Cancer Survivors in Europe: A Questionnaire Survey
por: Essig, Stefan, et al.
Publicado: (2012)

Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
por: Hashiguchi, Yasunori, et al.
Publicado: (2015)

Transplant characteristics and self-reported pulmonary outcomes in Swiss childhood cancer survivors after hematopoietic stem cell transplantation—a cohort study
por: Otth, Maria, et al.
Publicado: (2020)

VIRAL INFECTIONS: THE MOST COMMONLY IDENTIFIED CAUSE OF FEVER IN CHILDREN WITH CHEMOTHERAPY-INDUCED NEUTROPENIA † 1041
por: Korones, David N, et al.
Publicado: (1996)

Physical Performance Limitations in Adolescent and Adult Survivors of Childhood Cancer and Their Siblings
por: Rueegg, Corina S., et al.
Publicado: (2012)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

Management of chemotherapy-associated febrile neutropenia
por: Cameron, D
Publicado: (2009)

Cause‐specific long‐term mortality in survivors of childhood cancer in Switzerland: A population‐based study
por: Schindler, Matthias, et al.
Publicado: (2016)

No evidence of response bias in a population-based childhood cancer survivor questionnaire survey — Results from the Swiss Childhood Cancer Survivor Study
por: Rueegg, Corina S., et al.
Publicado: (2017)

Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?
por: Boccia, Ralph, et al.
Publicado: (2022)

Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective?
por: Zimmer, Andrea J, et al.
Publicado: (2022)

Patterns of Bacterial Isolates and their Resistance to Antibiotics in Patients with Chemotherapy-induced Febrile Neutropenia at a University Hospital
por: Al Saifi, Said Ahmed, et al.
Publicado: (2021)

Prevention of febrile neutropenia: use of prophylactic antibiotics
por: Cullen, M, et al.
Publicado: (2009)

Ibrutinib: Grade 3 neutropenia and fever: case report
Publicado: (2022)

Bendamustine/rituximab: Neutropenia, fever and inflammation: case report
Publicado: (2022)

Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia
por: Hoggatt, Jonathan, et al.
Publicado: (2015)

Properdin Levels in Individuals with Chemotherapy-Induced Neutropenia
por: Tsyrkunou, Artsiom, et al.
Publicado: (2016)

Daily Physical Activities and Sports in Adult Survivors of Childhood Cancer and Healthy Controls: A Population-Based Questionnaire Survey
por: Rueegg, Corina S., et al.
Publicado: (2012)

Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study
por: Pelzer, Florian, et al.
Publicado: (2018)

Retrospective survey and evaluation of first-line antibiotics for chemotherapy-induced febrile neutropenia in patients with acute myeloid leukemia
por: Mukoyama, Naoki, et al.
Publicado: (2017)

253. Febrile Neutropenia Antibiotic De-escalation Study in Acute Myeloid Leukemia Patients With Prolonged Neutropenia
por: Alegria, William, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q48nba94dehii57uhrg5sq0c9n